《港股》恆指低開194點 美團及藥明康德下滑
港元偏弱,金管局在紐約時段買入39.25億港元。港股在個別股份拖累下低開。恆指低開194點或0.8%,報24,982點;國指低開61點或0.7%,報8,976點;恆生科技指數低開31點或0.6%,報5,458點。
據報Prosus將進一步減持美團(03690.HK),美團低開3.1%報123.5元。京東(09618.HK)向歐洲消費電子產品零售商Ceconomy提購,股價低開0.9%報125.7元。新東方(09901.HK)股價低開1.6%報35.9元。其他科技股方面,阿里(09988.HK)及嗶哩嗶哩(09626.HK)低開0.9%及0.8%,騰訊(00700.HK)、百度(09888.HK)及中芯(00981.HK)各低開0.4%,網易(09999.HK)低開0.1%,快手(01024.HK)高開0.1%。
藥明康德(02359.HK)折讓6.9%配股淨籌76.5億元,股價低開4%報107.5元。同系藥明生物(02269.HK)低開2.8%。中生製藥(01177.HK)與默沙東授權合作順利,3億美元里程碑將於近期收款,股價高開2%報7.67元。
電池股寧德時代(03750.HK)中期純利增33%,股價低開1.3%報420元。車股方面,吉利(00175.HK)及小米(01810.HK)低開0.9%及0.8%,比亞迪(01211.HK)低開1.6%,理想(02015.HK)及小鵬(09868.HK)高開0.5%及0.8%。
金融股方面,匯控(00005.HK)、港交所(00388.HK)及友邦(01299.HK)低開1.2%至1.4%,本地地產股恆隆地產(00101.HK)昨午公布業績後造好,早市高開2.5%報8.15元。
百威亞太(01876.HK)半年純利跌24%,股價低開1.1%報8.67元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.